Creso Pharma Limited (CPH:ASX)


right-arrow Created with Sketch. 0 (0%)
MCAP $198.3M
Last trade 16.18pm 16/06/2021 20mins delayed

Latest Announcements

16/06/2021 Price SensitivePSCPHCreso Pharma Limited
11/06/2021CPHCreso Pharma Limited
08/06/2021CPHCreso Pharma Limited
04/06/2021CPHCreso Pharma Limited
03/06/2021CPHCreso Pharma Limited
26/05/2021CPHCreso Pharma Limited
24/05/2021CPHCreso Pharma Limited
24/05/2021CPHCreso Pharma Limited

Company Overview

Creso Pharma Limited is an Australia-based company engaged in developing cannabis and hemp-derived therapeutic-grade Nutraceuticals and Medical Cannabis products with a range of applications in both human and animal health. The Company's principal activity is to develop, register and commercialize pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments. The Company's segments include Hemp-Industries s.r.o. (Hemp-Industries), which includes hemp-growing operations, outsourced cannabidiol (CBD) extraction and CBD product sales activities; Creso Pharma Switzerland GmbH (Switzerland), which includes the development and commercialization of its therapeutic products, and Creso Pharma Limited (Creso), which includes the Company's corporate administration. The Company primarily offers human health and animal health products, and hemp-derived extracts, oils and proteins.

CPH in the news

Search Previous Announcements